International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Authors:
Open Access
- 27 November 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (12)
Abstract
Metabolic bariatric surgery (MBS) is the most effective long-term treatment option for clinical obesity and its complications1. Nonetheless, modern pharmacotherapy involving intestinal hormonal analogues, such as semaglutide and tirzepatide, have shown good weight loss outcomes in the short and medium term2–4. Potentially, such obesity management medications (OMMs) may be synergistic with or additive to MBS for selected patients before and/or after MBS regarding improved outcomes.Keywords
This publication has 27 references indexed in Scilit:
- Medium and Long-Term Weight Loss After Revisional Bariatric Surgery: A Systematic Review and Meta-AnalysisObesity Surgery, 2024
- IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management—an International Delphi StudyObesity Surgery, 2023
- Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic SurgeryJAMA Surgery, 2023
- Effectiveness of semaglutide versus liraglutide for treating post‐metabolic and bariatric surgery weight recurrenceObesity, 2023
- Gastric bypass versus best medical treatment for diabetic kidney disease: 5 years follow up of a single-centre open label randomised controlled trialeClinicalMedicine, 2022
- Systematic Review and Meta-Analysis of the Effectiveness of Insurance Requirements for Supervised Weight Loss Prior to Bariatric SurgeryObesity Surgery, 2021
- The Mitigating Effect of Phentermine and Topiramate on Weight Regain After Roux‐en‐Y Gastric Bypass SurgeryObesity, 2020
- Association of Preoperative Body Weight and Weight Loss With Risk of Death After Bariatric SurgeryJAMA Network Open, 2020
- Fighting Weight Bias and Obesity Stigma: a Call for ActionObesity Surgery, 2020
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular ComplicationsJAMA, 2014